Current Developments in Cell Replacement Therapy for Parkinson’s Disease-Reference-Cited by-同舟云学术

Current Developments in Cell Replacement Therapy for Parkinson’s Disease

Published:2021-05 Issue: Volume:463 Page:370-382
ISSN:0306-4522
Container-title:Neuroscience
language:en
Short-container-title:Neuroscience

Author:

Guo Xiaoqian,Tang Lisha,Tang Xiangqi

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

General Neuroscience

Reference69 articles.

1. Dopaminergic induction of umbilical cord mesenchymal stem cells by conditioned medium of choroid plexus epithelial cells reduces apomorphine-induced rotation in Parkinsonian rats;Aliaghaei;Arch Iran Med,2016

2. Recent advances of induced pluripotent stem cells application in neurodegenerative diseases;Amin;Prog Neuro-Psychopharmacol Biol Psychiatry,2019

3. Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease;Barker;Lancet Neurol,2013

4. Designing stem-cell-based dopamine cell replacement trials for Parkinson’s disease;Barker;Nat Med,2019

5. Human trials of stem cell-derived dopamine neurons for Parkinson's disease: dawn of a new era;Barker;Cell Stem Cell,2017

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress of neural stem cells as a source of dopaminergic neurons for cell therapy in Parkinson’s disease;Molecular Biology Reports;2024-02-24

2. Neural stem cell–derived exosomes regulate cell proliferation, migration, and cell death of brain microvascular endothelial cells via the miR‐9/Hes1 axis under hypoxia;Animal Models and Experimental Medicine;2024-02

3. Animal Model for Alzheimer’s Disease, Parkinson’s Disease, and Schizophrenia;Animal Models in Research;2024

4. Astragaloside IV Treats Parkinson’s Disease by Regulating the Proliferation and Differentiation of NSCs through the SHH–Nurr1 Pathway;Stem Cells International;2024-01

5. Zelltypen aus menschlichen pluripotenten Zellen und deren Anwendung in Zelltherapien;Gen- und Zelltherapie 2.023 - Forschung, klinische Anwendung und Gesellschaft;2023-12-30